Cellectar Biosciences, Inc.
CLRB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,444 | -$5,448 | -$6,604 | -$2,355 |
| Dep. & Amort. | $52 | $56 | $56 | $69 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $565 | $563 | $1,485 |
| Change in WC | -$176 | $176 | -$3,738 | -$64 |
| Other Non-Cash | $293 | -$465 | $340 | -$10,048 |
| Operating Cash Flow | -$4,275 | -$5,116 | -$9,383 | -$10,913 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $61 | $0 | -$61 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$61 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$61 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $5,788 | $2,251 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $5,788 | $2,251 | $0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,513 | -$2,864 | -$9,383 | -$10,975 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11,041 | $13,905 | $23,289 | $34,263 |
| End Cash | $12,554 | $11,041 | $13,905 | $23,289 |
| Free Cash Flow | -$4,275 | -$5,116 | -$9,383 | -$10,975 |